AU2005205797A1 - Multi-layer combination of an electric stimulation electrode and a wound dressing - Google Patents
Multi-layer combination of an electric stimulation electrode and a wound dressing Download PDFInfo
- Publication number
- AU2005205797A1 AU2005205797A1 AU2005205797A AU2005205797A AU2005205797A1 AU 2005205797 A1 AU2005205797 A1 AU 2005205797A1 AU 2005205797 A AU2005205797 A AU 2005205797A AU 2005205797 A AU2005205797 A AU 2005205797A AU 2005205797 A1 AU2005205797 A1 AU 2005205797A1
- Authority
- AU
- Australia
- Prior art keywords
- wound
- wound dressing
- dressing according
- layer
- coating
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 230000000638 stimulation Effects 0.000 title description 14
- 208000027418 Wounds and injury Diseases 0.000 claims description 140
- 206010052428 Wound Diseases 0.000 claims description 139
- 238000000576 coating method Methods 0.000 claims description 33
- 239000011248 coating agent Substances 0.000 claims description 31
- 239000003795 chemical substances by application Substances 0.000 claims description 26
- 239000011888 foil Substances 0.000 claims description 16
- 230000029663 wound healing Effects 0.000 claims description 12
- 230000001737 promoting effect Effects 0.000 claims description 9
- 239000000126 substance Substances 0.000 claims description 9
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 claims description 7
- 229910052709 silver Inorganic materials 0.000 claims description 7
- 239000004332 silver Substances 0.000 claims description 7
- 239000013543 active substance Substances 0.000 claims description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 5
- 239000000017 hydrogel Substances 0.000 claims description 4
- 239000000463 material Substances 0.000 claims description 4
- -1 polyethylene Polymers 0.000 claims description 4
- 229920005830 Polyurethane Foam Polymers 0.000 claims description 3
- 230000001070 adhesive effect Effects 0.000 claims description 3
- 235000010443 alginic acid Nutrition 0.000 claims description 3
- 239000000416 hydrocolloid Substances 0.000 claims description 3
- 239000011496 polyurethane foam Substances 0.000 claims description 3
- 239000004698 Polyethylene Substances 0.000 claims description 2
- 239000004743 Polypropylene Substances 0.000 claims description 2
- 229920001971 elastomer Polymers 0.000 claims description 2
- 239000003102 growth factor Substances 0.000 claims description 2
- 229910052751 metal Inorganic materials 0.000 claims description 2
- 239000002184 metal Substances 0.000 claims description 2
- 229920000573 polyethylene Polymers 0.000 claims description 2
- 229920001155 polypropylene Polymers 0.000 claims description 2
- 229920002635 polyurethane Polymers 0.000 claims description 2
- 239000004814 polyurethane Substances 0.000 claims description 2
- 241000894007 species Species 0.000 claims description 2
- 229920002994 synthetic fiber Polymers 0.000 claims description 2
- 239000000853 adhesive Substances 0.000 claims 2
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 claims 1
- 229940072056 alginate Drugs 0.000 claims 1
- 239000003242 anti bacterial agent Substances 0.000 claims 1
- 229940088710 antibiotic agent Drugs 0.000 claims 1
- 229940064004 antiseptic throat preparations Drugs 0.000 claims 1
- 229920001296 polysiloxane Polymers 0.000 claims 1
- 235000013343 vitamin Nutrition 0.000 claims 1
- 239000000499 gel Substances 0.000 description 13
- 230000035876 healing Effects 0.000 description 7
- 210000000416 exudates and transudate Anatomy 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 230000008901 benefit Effects 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 239000006096 absorbing agent Substances 0.000 description 2
- 229920000615 alginic acid Polymers 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 230000007717 exclusion Effects 0.000 description 2
- 239000012535 impurity Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000007769 metal material Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 239000004745 nonwoven fabric Substances 0.000 description 1
- 230000000474 nursing effect Effects 0.000 description 1
- 239000011505 plaster Substances 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000000284 resting effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/0404—Electrodes for external use
- A61N1/0408—Use-related aspects
- A61N1/0468—Specially adapted for promoting wound healing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/0404—Electrodes for external use
- A61N1/0472—Structure-related aspects
- A61N1/0492—Patch electrodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/0404—Electrodes for external use
- A61N1/0408—Use-related aspects
- A61N1/0464—Specially adapted for promoting tissue growth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/20—Applying electric currents by contact electrodes continuous direct currents
- A61N1/205—Applying electric currents by contact electrodes continuous direct currents for promoting a biological process
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Radiology & Medical Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Materials For Medical Uses (AREA)
Description
Our Ref: 12596121 P/00/011 Regulation 3:2
AUSTRALIA
Patents Act 1990
ORIGINAL
COMPLETE SPECIFICATION STANDARD PATENT Applicant(s): GerroMed Pflege- und Medizintechnik GmbH Co. KG Fangdieckstrasse 22547 Hamburg Germany Address for Service: Invention Title: DAVIES COLLISON CAVE Patent Trade Mark Attorneys Level 10, 10 Barrack Street Sydney, New South Wales, Australia, 2000 Multi-layer combination of an electric stimulation electrode and a wound dressing The following statement is a full description of this invention, including the best method of performing it known to me:- 5951 Description Multilayer combination of electrode for electrostimulation and wound dressing Technical field This invention starts from a wound dressing according to the preamble of claim 1.
Prior art From the prior art electrostimulation apparatuses are known which are used for the treatment of wounds, in particular of bad healing chronic wounds.
In the EP 0 504 715 Al, a wound treatment device is described which consists of an electrically non conductive layer which has an opening and of an electrically conductive non metallic material. Moreover, the wound treatment device has a substantially non adhering wound contact layer.
From the DE 201 03 311 US we know a wound coating which consists of a combination of an energy transfer agent and at least one wound coating means.
Here an electrode is used as energy transfer agent. However, the disadvantage of this device is that a homogeneous current distribution cannot be achieved by the electrode used. The electrodes used in the prior art, in particular close to the points of contact to which the current of the respective electrode is supplied, show current peaks so that an uniform eletrostimulation of the wound surface is consequently not possible. This results to the fact that in particular large surface injury wounds cannot be treated uniformly by such a wound coating.
Description of the invention, aim, solution, advantaqes The aim of this invention is to make available a combination of wound dressing and electrode for the stimulation treatment which which an uniform electrostimulation of the wound can be achieved so that the wound healing process is considerably improved.
A wound dressing with the characteristics of claim 1 is proposed to achieve this aim.
According to the invention, a novel wound dressing with an energy transfer agent, consisting of an energy supplying layer and an energy distribution layer, a wound coating and a protection and fixation layer is created which is used for the stimulation treatment, in particular with electrostimulation apparatuses.
To this purpose, it is foreseen according to the invention that the energy transfer agent has at least two adjacent layers, a first energy supplying layer and a second energy transferring layer. This being, it is of essential importance that the first layer has a lower electric resistance and the second layer a higher electric resistance. Due to such a configuration, it has shown that a homogeneous current distribution can be reached over the whole surface of the energy transfer agent. This being, the first layer which has a lower electric resistance provides the homogeneity. Then, the current flows into the second layer adjacent to the first layer which has a higher resistance.
Contrary to the known wound electrodes, it is thus possible with the subject of the invention to achieve a nearly uniform energy loaded stimulation treatement of the wound so that the wound healing process is considerably improved.
Preferable further developments of the wound dressing are described in claims 2 to 26.
In a preferred embodiment, the first layer has a protection and fixation layer on the side opposite to the second layer. A wound coating which rests directly on the wound to be treated is appropriately placed on the side of the second layer which is opposite to the first layer. One of the advantages of the wound dressing according to the invention is that the wound coating which serves for the protection and the care of the wound surface, must not, contrary to the known wound devices, be expressly removed for a stimulation treatment, which would not be beneficial to the healing process of the wound. For each change of the wound dressing is always connected despite of a thorough cleaning of the wound with a risk of infection. But the would dressing according to the invention remains on the wound to be treated, even if no stimulation treatment is carried out.
Besides the saving of dressing material, a considerable reduction of the treatment time through the nursing staff is achieved due to the wound dressing according to the invention.
Preferably the first layer is a silver layer so that a low electric resistance is obtained in the first layer. The incoming current is homogenously distributed in the silver layer over the whole surface of the energy transfer agent because of its good electrically conductive properties and then arrives over the second layer into the wound coating. Thus, the silver layer constitutes an effective means of the wound dressing according to the invention in order to obtain an uniform stimulation treatment of the wound to be dressed. Furthermore, due to the use of the silver layer there results the possibility to place a current feed at any point of the energy transfer agent since an optimal current distribution is guaranteed even for a lateral arrangement or for example at a corner of the energy transfer agent. Current peaks are nearly avoided by this wound dressing according to the invention. An additional advantage of the silver layer is that it has an antimicrobial effect which is particularly positive in the healing process of wound surfaces.
According to the invention, it is foreseen that the wound coating is hydrophilic and electrically conductive, whereby the wound coating can be a gel, in particular a hydrogel. It is also conceivable to use hydrocolloids, alginates or polyurethane foams as wound coating. Contrary to the known inactive wound coatings, in particular gauze compresses, pads or absorbent nonwovens, the afore mentioned wound coatings, in particular hydrogels are to be preferred for the treatment of damaged skin and wounds. The advantage of their use is, among others, that they have a good biological tolerance, in particular when they are applied during a longer period of time. Because of the hydrophilic property, the wound coating can absorb liquid such as wound exudat (protein containing liquid which comes out from the vessels by inflammations) in bigger quantities by an increase in volume without losing its coherence. Furthermore, due to the homogeneous electric conductivity of the wound coating, the electrostimulation can easily pass through and arrives uniformly to the wound area to be treated. It is particularly advantageous that due to the electrostimulation of the wound coating 0 or of the wound heat is fed as well so that, according to medical findings, a better and quicker healing process is obtained.
In particular due to the exclusion of atmospheric oxygen from the wound, the Nhealing process can be further accelerated because the wound is forced to bring oxygen into the wound area over the blood. This takes place by an increased formation of new vessels so that the wound healing is improved. This being, hydrogel as well as hydrocolloids, alginates or polyurethane foams are appropriate means to create such nearly oxygen-free conditions in the wound.
0 In a further preferred embodiment of the wound dressing, the wound coating can Shave wound healing promoting substances. This being, the substances are preferably growth factors. While the wound coating rests on the wound area to be treated and absorbs wound exudate, it simultaneously sets wound healing promoting substances free for the wound so that the healing process of the wound is accelerated. In particular for bad healing chronic wounds, a wound coating with wound healing promoting substances is advantageous.
An electrode for the electrostimulation can be used as energy transfer agent for the wound dressing according to the invention. It is also conceivable to configure the energy transfer agent as a foil. Appropriately the energy transfer agent has an electrical connecting means which can be connected with the energy producer which supplies the wound dressing during the stimulation treatment with current or with electric pulses. Preferably the connecting means is placed on the first layer which goes for example through an opening provided in the protection/fixation layer above and which can be connected with the energy producer.
Preferably metal or an electrically conductive synthetic material, in particular rubber, is conceivable for the energy transfer agent.
Furthermore, the wound dressing has on the side opposite to the energy transfer agent an additional layer which is preferably a peelable foil. Such a layer protects the wound coating from impurities. The foil can be easily removed from the wound dressing before applying onto the wound area. This being it is advantageous if the foil preferably made of polyethylene, polypropylene or polyurethane is impermeable to water and active substances. After the foil has been removed from the wound dressing, the wound dressing according to the invention is applied onto the wound. The wound coating appropriately has adhesive properties on its surface opposite to the wound so that a reliable application on the wound surface is guaranteed.
It is particularly advantageous that the wound dressing is flexible and elastic so that it can be adapted to the contour of the human body, in particular to special parts of the body.
Short description of the drawings The invention will be explained in detail below with reference to the attached drawings.
Fig. 1 shows a top view of an embodiment of a wound dressing according to the invention.
Fig. 2 shows a pure schematic section according of line I1-11i of the wound dressing according to the invention according to fig. 1.
Fig. 3 shows a top view of a second embodiment of a wound dressing according to the invention.
Fig. 4 shows a pure schematic section according to line Ill-IV of the wound dressing according to the invention according to fig. 3.
Preferred embodiment of the invention Fig. 1 and 2 show a preferred embodiment of a wound dressing according to the invention 100. The wound dressing 100 has an energy transfer agent 11, 12 in form of a two-layer electrode which is configured with a first energy supplying layer 11 and a second energy distributing layer 12. These layers 11, 12 rest on each other with their upper faces. In order to guarantee an uniform current distribution on the surface of the energy transfer agent 11, 12, the first layer 11 is a silver layer. The aim of this is that this layer is of low impedance or that it has a lower electric resistance. On the side opposite to the second layer 12, a protection/fixation layer 10 which covers the energy transfer agent 11, 12, is placed on the first layer 11 so that the energy transfer agent is fixed on the surrounding skin. This being, the non electrically conductive protection/fixation layer consists of plastic foil type material. It is also possible to make the protection/fixation layer 10 for example of plaster foil type or foam foil type material.
An opening 16 which is illustrated in particular in fig.2 is placed for the represented embodiment on the protection/fixation layer 10 in order to be able to realize an electrical connection with the electrode 11, 12 covered by the protection/fixation layer 10. An electrical contact 15 which consists of the first and second layer 11/12 passes through the opening 16. Like in the represented embodiment, the opening 16 can be configured for example as a shackle which can be bent up. The end of the electrical contact 15 can be connected with an energy producer which however is not shown in the figures.
A wound coating 13 which is a gel 13 in the represented embodiment is placed below the second layer 12 on the side opposite to the first layer 11. This gel is hydrophilic and electrically conductive and can contain wound healing promoting substances. The gel 13 is in direct contact with the wound/skin 14. However, before the wound dressing 100 is applied on the wound 14, a foil (which is not represented) is removed which is placed on the surface of the gel 13 and thus protects the gel 13 from impurities. However, it is important that a slight stripping of the foil is possible without removing areas from the wound coating 13 at the same time. The foil is configured impermeable to water and active substances so that the wound dressing 100, in particular the gel 13, does not lose liquid or the wound healing promoting substances during storage.
After the foil has been removed, the wound dressing 100 is applied onto the wound to be treated 14. The gel has adhesive properties on its surface so that it remains sticked efficiently on the skin/wound 14 even over longer periods of time.
During the stimulation treatment, the wound dressing 100 is loaded with current, in particular with pulses. This being, the current flows from the energy producer over the electrical contact 15 into the first layer energy supply 11 of the electrode 11, 12. Because of the low resistance of the first layer 11, the current is uniformly distributed and flows then into the second layer energy distribution
I
P:\WPDOCS\ARS\SPECIE\12578641.doc-31/0805 -7- 12 with the higher resistance. From there the electronic stimulation is further transmitted by the subjacent gel 13 which has a homogeneous electrical conductivity to the wound 14 so that an uniform stimulation over the wound surface 14 can be achieved with the represented embodiment.
During the stimulation treatment, the gel 13 can release wound healing promoting active substances to the wound 14 so that the healing process can be accelerated. Simultaneously the gel 13 is able, because of its composition, to absorb wound exudate in higher quantities. This being, the absorbency of liquid (such as water oder wound exudate) is guaranteed by absorbers. Polymers are for example appropriate as absorbers. Moreover, the gel 13 has a stable structure, in particular during the stimulation treatment of the wound 14 and during the resting on the wound 14.
Fig. 3 and 4 show a further preferred embodiment of the wound dressing 100. The same parts have the same reference numerals as the corresponding parts in Fig. 1 and 2 and the same description is valid for them. The difference consists in the lateral arrangement of the electrical contact 13 which serves as connecting means and which is here connected with the layers 11, 12 by being laterally led through.
Throughout this specification and the claims which follow, unless the context requires otherwise, the word "comprise", and variations such as "comprises" or "comprising", will be understood to imply the inclusion of a stated integer or step or group of integers or steps but not the exclusion of any other integer or step or group of integers or steps.
The reference to any prior art in this specification is not, and should not be taken as, an acknowledgment or any form of suggestion that that prior art forms part of the common general knowledge in Australia.
The reference numerals in the following claims do not in any way limit the scope of the respective claims.
8 LIST OF REFERENCE NUMERALS 100 Wound dressing Protection/fixation layer 11 First layer of the energy transfer agent energy supply 12 Second layer of the energy transfer agent energy distribution 13 Wound coating/gel 14 Skin, wound Connecting means, electrical contact 16 Opening
Claims (21)
1. Wound dressing (100) with at least one energy transfer medium (11, 12) and a wound coating (13), characterized in that the energy transfer agent has at least two layers and that the energy transfer agent (11, 12) has at least two adjacent layers (11, 12), a first layer (11) for the energy supply and a second energy for the distribution of en- ergy whereby the first layer has a lower electric resistance and the second layer (12) a higher electric resistance.
2. Wound dressing according to claim 1, characterized in that the first layer (11) has a protection/fixing layer (10) on the side oppo- site to the second layer (12).
3. Wound dressing according to claim 1 or 2, characterized in that the second layer (12) has a wound coating (13) on the side opposite to the first layer (11).
4. Wound dressing according to any of the preceding claims, characterized in that the first layer (11) is for example a silver layer. Wound dressing according to any of the preceding claims, characterized in that the wound coating (13) is hydrophilic.
6. Wound dressing according to any of the preceding claims, characterized in that the wound coating (13) is electrically conductive.
7. Wound dressing according to any of the preceding claims, characterized in that the wound coating (13) is heat conducting and/or is heat producing when loaded with energy.
8. Wound dressing according to any of the preceding claims, characterized in Sthat the wound coating has adhesive properties. V. 9. Wound dressing according to any of the preceding claims, Scharacterized in that the wound coating (13) is for example a hydrogel, hydrocolloid, algi- nate or a polyurethane foam. n 10. Wound dressing according to any of the preceding claims, c characterized in that the wound coating (13) has wound healing promoting substances.
11. Wound dressing according to claim characterized in that the wound healing promoting substance is a growth factor.
12. Wound dressing according to claim characterized in that the wound healing (promoting) substance contains antibiotics, antisep- tics, vitamines, anageltics or other active substances.
13. Wound dressing according to any of the preceding claims, characterized in that the energy transfer agent (11, 12) is an electrode for electrostimula- tion.
14. Wound dressing according to any of the preceding claims, characterized in that the energy transfer agent (11, 12) is a foil. Wound dressing according to any of the preceding claims, characterized in that the energy transfer agent (11, 12) is made of metal or electrically con- ductive synthetic material, in particular rubber, or silicone.
16. Wound dressing according to any of the preceding claims, characterized in that the energy transfer agent (11, 12) has an electrical connecting means which can be connected with an energy producer.
17. Wound dressing according to any of the preceding claims, characterized in that the connecting means (15)is placed on the first layer (11).
18. Wound dressing according to any of the preceding claims, characterized in that the connecting means (15) is placed on the first and second layer (11, 12).
19. Wound dressing according to any of the preceding claims, characterized in that the protection/fixation layer (10) is configured with an opening (16). Wound dressing according to any of the preceding claims, characterized in that the protection/fixation layer (10) is made of self-adhesive water va- pour permeable material.
21. Wound dressing according to any of the preceding claims, characterized in that the wound coating (13) has an additional layer on the side opposite to the energy transfer agent (11, 12).
22. Wound dressing according to claim 21, characterized in that the additional layer is a peelable foil.
23. Wound dressing according to claim 22, characterized in that the foil is made of polyethylene, polypropylene or polyurethane.
24. Wound dressing according to claim 22 or 23, P;\WPDOCS\ARS\SPECIE\I257864l.doc-31/08/05 12- characterized in that the foil is impermeable to water and active substances. Wound dressing according to any of the preceding claims, characterized in that the wound coating means (13) has self-adhesive properties.
26. Wound dressing according to any of the preceding claims, characterized in that the wound dressing (100) is flexible and elastic.
27. Wound dressing substantially as hereinbefore described with reference to the accompanying drawings. Dated this 1st day of September, 2005 GERROMED PFLEGE- UND MEDIZINTECHNIK GMBH By Its Patent Attorneys DAVIES COLLISON CAVE
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2005205797A AU2005205797B2 (en) | 2003-02-07 | 2005-09-02 | Multi-layer combination of an electric stimulation electrode and a wound dressing |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE20301973.3 | 2003-02-07 | ||
| AU2004210417 | 2004-02-05 | ||
| AU2005205797A AU2005205797B2 (en) | 2003-02-07 | 2005-09-02 | Multi-layer combination of an electric stimulation electrode and a wound dressing |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/EP2004/001059 Division WO2004069088A2 (en) | 2003-02-07 | 2004-02-05 | Multi-layer combination of an electric stimulation electrode and a wound dressing |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2005205797A1 true AU2005205797A1 (en) | 2005-09-29 |
| AU2005205797B2 AU2005205797B2 (en) | 2008-11-13 |
Family
ID=35057924
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2005205797A Expired AU2005205797B2 (en) | 2003-02-07 | 2005-09-02 | Multi-layer combination of an electric stimulation electrode and a wound dressing |
Country Status (1)
| Country | Link |
|---|---|
| AU (1) | AU2005205797B2 (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2013140176A1 (en) * | 2012-03-23 | 2013-09-26 | Archimed Llp | Skin dressing with electrodes and physiologically active precursor substance |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3964477A (en) * | 1975-01-30 | 1976-06-22 | Sybron Corporation | Method of using electrodes having antiseptic properties for LIDC therapy |
| US6438428B1 (en) * | 1999-10-27 | 2002-08-20 | Axelgaard Manufacturing Co., Ltd. | Electrical stimulation compress |
-
2005
- 2005-09-02 AU AU2005205797A patent/AU2005205797B2/en not_active Expired
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2013140176A1 (en) * | 2012-03-23 | 2013-09-26 | Archimed Llp | Skin dressing with electrodes and physiologically active precursor substance |
| US9717891B2 (en) | 2012-03-23 | 2017-08-01 | Microarray Limited | Skin dressing with electrodes and physiologically active precursor substance |
| RU2630586C2 (en) * | 2012-03-23 | 2017-09-11 | Микроэррей Лимитед | Skin dressing with electrodes and precursor of physiologically active substance |
Also Published As
| Publication number | Publication date |
|---|---|
| AU2005205797B2 (en) | 2008-11-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US7689285B2 (en) | Multi-layer combination of an electric stimulation electrode and a wound dressing | |
| US5974344A (en) | Wound care electrode | |
| EP2461863B1 (en) | Surgical wound dressing incorporating connected hydrogel beads having an embedded electrode therein | |
| CA2449556C (en) | Hydrogel and scrim assembly for use with electro-acupuncture device with stimulation electrodes | |
| CN102448507B (en) | Adopt reduced pressure treatment systems and the method for hydrogel reservoir member | |
| ES2543082T3 (en) | Wound dressing | |
| ES2286260T3 (en) | APPARATUS TO FACILITATE WOUND HEALING. | |
| ES2430688T3 (en) | Medical device | |
| US5848966A (en) | Medical device easily removed from skin and a method of removal therefrom | |
| WO2003043553A1 (en) | A wound dressing | |
| TW201019912A (en) | Multi-layer dressings, systems, and methods for applying reduced pressure at a tissue site | |
| JP2007504882A5 (en) | ||
| WO2005023361A3 (en) | Disposable electric bandage | |
| US20090048651A1 (en) | Medical electrode systems and methods | |
| US7177705B2 (en) | Surface electrode for electrical stimulation of tissue | |
| US20110009792A1 (en) | Wound dressing and preservation of exit site of an orthopedic pin or tube extruding from the skin | |
| AU2005205797B2 (en) | Multi-layer combination of an electric stimulation electrode and a wound dressing | |
| CN1634606A (en) | Externally applied acesodyne electret film for medical use and method for manufacturing the same | |
| US20090048504A1 (en) | Medical electrode systems and methods | |
| US20090048635A1 (en) | Medical electrode systems and methods | |
| CN211156688U (en) | Dressing device | |
| CN206934247U (en) | A kind of electromagnetic induction analgesia bearing hydrocolloid dressing | |
| CN110786993A (en) | Protective plaster for treating acute mastitis | |
| RU24379U1 (en) | APPLICATOR | |
| 金子哲男 et al. | Characteristics of novel hydrogel dressing material |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FGA | Letters patent sealed or granted (standard patent) | ||
| DA2 | Applications for amendment section 104 |
Free format text: THE NATURE OF THE AMENDMENT IS: AMEND THE NAME OF THE INVENTOR FROM BARABET, LUCA TO GARABET, LUCA. |
|
| DA3 | Amendments made section 104 |
Free format text: THE NATURE OF THE AMENDMENT IS: AMEND THE NAME OF THE INVENTOR FROM BARABET, LUCA TO GARABET, LUCA |
|
| HB | Alteration of name in register |
Owner name: WOUNDEL GMBH Free format text: FORMER NAME(S): GERROMED PFLEGE- UND MEDIZINTECHNIK GMBH & CO. KG |
|
| PC | Assignment registered |
Owner name: WOUNDEL HEALTH CARE Free format text: FORMER OWNER(S): WOUNDEL GMBH |
|
| MK14 | Patent ceased section 143(a) (annual fees not paid) or expired |